Sleep Initiation and Maintenance Disorders: Wilson S

 Topic:  
Hints · Remembered Topics    
  Start Here  Overview  World Articles  Find Experts  Books & DVDs  Help 
 
Column View Map 5 Articles   Help
A digest of articles written 1999 and later, on the topic "Sleep Initiation and Maintenance Disorders," originating from Planet Earth —» Wilson S.  Display:  All Citations ·  All Abstracts
1 Editorial Drug treatment of chronic insomnia -- dawn at the end of a long night? 2008

Wilson S, Nutt D. · No affiliation provided · J Psychopharmacol. · Pubmed #18753272 No free full text.

This publication has no abstract.

2 Review Antidepressants and sleep: a qualitative review of the literature. 2005

Wilson S, Argyropoulos S. · Psychopharmacology Unit, University of Bristol, Bristol, UK. · Drugs. · Pubmed #15892588 No free full text.

Abstract: Most antidepressants change sleep; in particular, they alter the physiological patterns of sleep stages recorded overnight with EEG and other physiological measures. These effects are greatest and most consistent on rapid eye movement (REM) sleep, and tend to be in the opposite direction to the sleep abnormalities found in major depression, but are usually of greater degree. Reductions in the amount of REM sleep and increases in REM sleep onset latency are seen after taking antidepressants, both in healthy volunteers and in depressed patients. Antidepressants that increase serotonin function by blocking reuptake or by inhibiting metabolism have the greatest effect on REM sleep. The decrease in amount of REM sleep appears to be greatest early in treatment, and gradually diminishes during long-term treatment, except after monoamine oxidase inhibitors when REM sleep is often absent for many months. Sleep initiation and maintenance are also affected by antidepressants, but the effects are much less consistent between drugs. Some antidepressants such as clomipramine and the selective serotonin receptor inhibitors (SSRIs), particularly fluoxetine, are sleep-disturbing early in treatment and some others such as amitriptyline and the newer serotonin 5-HT2-receptor antagonists are sleep promoting. However, these effects are fairly short-lived and there are very few significant differences between drugs after a few weeks of treatment. In general, the objectively measured sleep of depressed patients improves during 3-4 weeks of effective antidepressant treatment with most agents, as does their subjective impression of their sleep. Sleep improvement earlier in treatment may be an important clinical goal in some patients, perhaps when insomnia is particularly distressing, or to ensure compliance. In these patients, the choice of a safely used and effective antidepressant which improves sleep in short term is indicated. Patients with other sleep disorders such as restless legs syndrome and REM sleep behaviour disorder should be identified before choosing a treatment, as some antidepressants worsen these conditions. Conversely, there is evidence that some antidepressants may be useful in the treatment of sleep disorders such as night terrors.

3 Review Assessment and management of insomnia. 2005

Wilson S, Nutt D. · Psychopharmacology Unit, University of Bristol. · Clin Med. · Pubmed #15846998 No free full text.

This publication has no abstract.

4 Article Management of insomnia: treatments and mechanismsi. free! 2007

Wilson S, Nutt D. · Psychopharmacology Unit, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, UK. · Br J Psychiatry. · Pubmed #17766757 links to  free full text

Abstract: Management of insomnia is an interesting subject at present. New drug treatments are now becoming available after a relatively static period since the development of the Z-drugs in the 1990s. Moreover, more evidence is coming to light about the length of drug treatment and the effectiveness of psychological therapies. This article briefly describes current treatments, both evidence-based and common practice, and goes on to describe some emerging approaches.

5 Article Evaluation of severe insomnia in the general population--implications for the management of insomnia: the UK perspective. 1999

Nutt DJ, Wilson S. · Psychopharmacology Unit, School of Medical Sciences, Bristol, UK. · J Psychopharmacol. · Pubmed #10667457 No free full text.

This publication has no abstract.